A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PH / pulmonary hypertension

[Related PubMed/MEDLINE]
Total Number of Papers: 4106
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PH  (>> Co-occurring Abbreviation)
Long Form:   pulmonary hypertension
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 2-Methoxyestradiol attenuates chronic-intermittent-hypoxia-induced pulmonary hypertension through regulating microRNA-223. 2-ME, CIH, miR-223, OSA, PASMCs
2019 3-Bromopyruvate Attenuates Experimental Pulmonary Hypertension via Inhibition of Glycolysis. 3-BrPA, HK2, MCT
2019 A Case of Bilateral Spontaneous Chylothorax with Respiratory Syncytial Virus Bronchiolitis. RSV
2019 A diagnostic algorithm for pulmonary hypertension due to left heart disease in resource-limited settings: can busy clinicians adopt a simple, practical approach? RHC
2019 A Prospective Evaluation of the Diagnostic Accuracy of the Physical Examination for Pulmonary Hypertension. AUC, JVP, LRs, RAP
2019 Abnormal Ventilation-Perfusion Scan Is Associated with Pulmonary Hypertension in Sickle Cell Adults. CTEPH, CTPA, RHC, SCD
2019 Accuracy of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data: A Systematic Review. ICD, PAH
2019 Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary circulation in patients with systemic sclerosis. EDE, PVR, RHC, SSc, TRPG
2019 Acute Pulmonary Hypertension Crisis after Adalimumab Reduction in Rheumatoid Vasculitis. ---
10  2019 Acute Vasoreactivity Testing during Cardiac Catheterization of Neonates with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension. AVT, BPD
11  2019 Adenosine and hyaluronan modulate lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema (CPFE). CPFE, HAS
12  2019 Adventitial growth and lung connective tissue growth factor expression in pulmonary arterioles due to hypobaric hypoxia in broilers. CTGF
13  2019 Alterations in cardiovascular function in an experimental model of lung fibrosis and pulmonary hypertension. TBXA2R
14  2019 Altered Expression of Zinc Transporter ZIP12 in Broilers of Ascites Syndrome Induced by Intravenous Cellulose Microparticle Injection. AS, PAS
15  2019 Analysis of Biphasic Right Ventricular Outflow Doppler Waveform in Patients with Pulmonary Hypertension. PVD, PVR, RVDF, RVOT
16  2019 Anti-RNA binding protein positivity in idiopathic interstitial pneumonia. anti-RBP, CTD, IIP, PFT
17  2019 AOS ameliorates monocrotaline-induced pulmonary hypertension by restraining the activation of P-selectin/p38MAPK/NF-kappaB pathway in rats. AOS
18  2019 Association Between Pulmonary Hypertension and Transcatheter Aortic Valve Replacement: Analysis of a Nationwide Inpatient Sample Database. NIS, TAVR
19  2019 Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathy. MBF, MFR
20  2019 Autophagy in pulmonary hypertension: Emerging roles and therapeutic implications. ---
21  2019 Beneficial Effects of Imatinib in a Patient with Suspected Pulmonary Veno-Occlusive Disease. NO, PAH, PVOD
22  2019 Birth Size and Gestational Age Specific Outcomes of Inhaled Nitric Oxide Therapy in Preterm Neonates with Clinically Diagnosed Pulmonary Hypertension. GA, iNO, RDS
23  2019 BOLA3 Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension. BOLA3, GCSH, PAECs
24  2019 Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension. BMP9, PAH, POPH
25  2019 Borderline pulmonary hypertension associated with chronic hypercapnia in chronic pulmonary disease. HCHX, HCnx, ncHX, ncnx, PAm
26  2019 Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension. BMDM, CAI, PAH, PAs, PASMC, VSMC
27  2019 Cardiac Magnetic Resonance Imaging-Based Right Ventricular Strain Analysis for Assessment of Coupling and Diastolic Function in Pulmonary Hypertension. CI, CMR, Ea, Ea, Eds, Eed, OR, RV
28  2019 Cardiac mechanics in infants with Down syndrome in the early neonatal period. CHD, DS
29  2019 Cardiovascular Outcomes of Patients With Pulmonary Hypertension Undergoing Noncardiac Surgery. MACCE
30  2019 Circulating Apoptotic Signals During Acute and Chronic Exposure to High Altitude in Kyrgyz Population. ASs, CASs, FasL, HA, HAPH, PASMCs
31  2019 Clinical and echocardiographic correlates of pulmonary hypertension among heart failure patients in Lagos, south-western Nigeria. HF, LV, MR, PASP, RV
32  2019 Clinical and hemodynamic factors in predicting response to fluid challenge during right heart catheterization. NFC, PAWP, PFC
33  2019 Clinical and imaging manifestations of Takayasu's arteritis with pulmonary hypertension: A retrospective cohort study in China. 6MWD, PTA
34  2019 Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients. FEV1, LAM, PAP, sPAP, TRV
35  2019 Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension. 6MWD, NT-proBNP, RHC, SAPH
36  2019 Clinical implication of right-sided augmentation pressure in patients with pulmonary hypertension. AugPr, mPAP, RV
37  2019 Comprehensive three-dimensional morphology of neoangiogenesis in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. PCH, PVOD
38  2019 Correction of pulmonary hypertension with intensive hemodialysis: A case report. ---
39  2019 Correlation of Right Ventricular Wall Stress With Plasma B-Type Natriuretic Peptide Levels in Patients With Pulmonary Hypertension. BNP, LVWS, RHC, RVWS
40  2019 Dasatinib-induced pulmonary arterial hypertension complicated with scleroderma: a case report. DASA-PAH
41  2019 Death or resolution: the "natural history" of pulmonary hypertension in bronchopulmonary dysplasia. BPD, ECHO, GA, PAP, PMA, PVS
42  2019 Detection of Plasma Catecholamines in Human Pheochromocytoma and Primary Hypertension Based on Liquid Chromatography Tandem Mass Spectrometry. CAs, DA, DNS-Cl, HVA, MN, NE, NMN, VMA
43  2019 Development of best practice recommendations for the safe use of pulmonary hypertension pharmacotherapies using a modified Delphi method. BPR
44  2019 Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18-24 months of corrected age. Bayley-III, BPD, CA
45  2019 Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension. DM
46  2019 Diagnosis and Pathophysiological Mechanisms of Group 3 Hypoxia-Induced Pulmonary Hypertension. FGF, PDGFB, VEGF-A
47  2019 Diagnosis of pulmonary hypertension using spectral-detector CT. CTEPH, SDCT
48  2019 Diagnosis of Pulmonary Hypertension with Cardiac MRI: Derivation and Validation of Regression Models. CI, mPAP, RHC, ROC
49  2019 Distinct plasma gradients of microRNA-204 in the pulmonary circulation of patients suffering from WHO Groups I and II pulmonary hypertension. miR, PAH, PASMCs, PBMCs, WHO
50  2019 Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension. HIF, MCT, PAECs, PASMCs
51  2019 Do radiologists detect chronic thromboembolic disease on computed tomography? CT, CTEPH
52  2019 Doppler-defined pulmonary hypertension in sepsis and septic shock. TRV
53  2019 Double-lung versus heart-lung transplantation for precapillary pulmonary arterial hypertension: a 24-year single-center retrospective study. CHD, CLAD, HLT
54  2019 Drug repositioning in pulmonary arterial hypertension: challenges and opportunities. PAH
55  2019 Early intervention: should we conduct therapeutic trials for mild pulmonary hypertension before onset of symptoms? mPAP, PAH
56  2019 Echocardiographic assessment of pulmonary arterial stiffness in human immunodeficiency virus-infected patients. HIV, PAP, PAS
57  2019 Echocardiographic evaluation of left ventricular filling pressures in patients with pulmonary hypertension. AUC, LVFP
58  2019 Echocardiographic right ventricular strain from multiple apical views is superior for assessment of right ventricular systolic function. RIMP, RV, RVEFCMR, RVFAC, RVGLS, TAPSE
59  2019 Effect of a phosphodiesterase-5A (PDE5A) gene polymorphism on response to sildenafil therapy in canine pulmonary hypertension. cGMP, PDE5, PDE5A, PG, QOL
60  2019 Effect of beraprost on pulmonary hypertension due to left ventricular systolic dysfunction. PAP
61  2019 Effect of iloprost inhalation on postoperative outcome in high-risk cardiac surgical patients: a prospective randomized-controlled multicentre trial (ILOCARD). CI, RV
62  2019 Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study. CMR, iPVR, mPAP, PA, PADN
63  2019 Effectiveness of long-term using statins in COPD - a network meta-analysis. COPD, CRP
64  2019 Effectiveness of pulmonary vasodilators on pulmonary hypertension associated with POEMS syndrome. POEMS, sPAP, VEGF
65  2019 Effects of Beet Juice Supplementation on Monocrotaline-Induced Pulmonary Hypertension in Rats. BJ, MCT
66  2019 Efficacy and safety of a novel nitric oxide generator for the treatment of neonatal pulmonary hypertension: Experimental and clinical studies. NO, OI, PAP, PPHN
67  2019 Electrocardiogram signs of right ventricular hypertrophy may help identify pulmonary hypertension in patients with dilated cardiomyopathy. DCM, ECG, RVH, SV5, SV6
68  2019 ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension. ---
69  2019 Evolving systems biology approaches to understanding non-coding RNAs in pulmonary hypertension. ---
70  2019 Evolving use of natriuretic peptide receptor type-C as part of strategies for the treatment of pulmonary hypertension due to left ventricle heart failure. LVHF, NPR-C
71  2019 Exercise capacity in borderline mean pulmonary artery pressure: Is it all about peak VO2 ? boPAP, CPET, mPAP
72  2019 Exercise-Induced Changes in Pulmonary Artery Stiffness in Pulmonary Hypertension. CI, MPA, MRI, PA, PWV, RAC, RHC, RV
73  2019 Exploration of the Notch3-HES5 signal pathway in monocrotaline-induced pulmonary hypertension using rat model. mPAP, RVHI, RVSP
74  2019 Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia. BPD
75  2019 Expression of soluble receptor for advanced glycation end products (sRAGE) is associated with disease severity in congenital diaphragmatic hernia. CDH, ECMO, sRAGE
76  2019 Factors influencing decision making in neonatology: inhaled nitric oxide in preterm infants. iNO
77  2019 Fetal endoscopic tracheal occlusion reduces pulmonary hypertension in severe congenital diaphragmatic hernia. CDH, ECMO, FETO, GA
78  2019 FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension. FHIT, PAH
79  2019 Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure. PAH, RV, SD
80  2019 Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms. MPN, TTE
81  2019 Galectin-3 is expressed in vascular smooth muscle cells and promotes pulmonary hypertension through changes in proliferation, apoptosis, and fibrosis. Gal-3, MCT, PAs, PASMCs
82  2019 Gasometric gradients between blood obtained from the pulmonary artery wedge and pulmonary artery positions in pulmonary arterial hypertension. PA, PAH, PAW, RHC
83  2019 Genipin attenuates hyperoxia-induced lung injury and pulmonary hypertension via targeting glycogen synthase kinase-3 beta in neonatal rats. GSK, LV, mRNA, RV
84  2019 Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension. DPP-4i, EndMT, GLP-1, HUVECs, PVR, RVSP
85  2019 Haemodynamic definitions and updated clinical classification of pulmonary hypertension. mPAP, PAH, WSPH
86  2019 Haemodynamic mechanisms and long-term prognostic impact of pulmonary hypertension in patients with severe aortic stenosis undergoing valve replacement. AS, LVEDP, mPAWP, PVR
87  2019 Harvest of Endothelial Cells from the Balloon Tips of Swan-Ganz Catheters after Right Heart Catheterization. PAECs, RHC
88  2019 Hemodynamic changes after acute fluid loading in patients with systemic sclerosis without pulmonary hypertension. PAWP, SSc
89  2019 Highlights from the ERS International Congress 2018: Assembly 13 - Pulmonary Vascular Diseases. ERS, PVD
90  2019 HMGB1 is mechanistically essential in the development of experimental pulmonary hypertension. 2-APB, HMGB1, PASMCs, TLR4, TRPC
91  2019 HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling. BMPR2, HMGB1, Id1, IL-1beta, IL-6, IPAH, PASMCs, TLR4, TNF-alpha
92  2019 Hospitalisations for heart failure predict mortality in pulmonary hypertension related to congenital heart disease. ACHD, HF, NYHA
93  2019 Hospitalizations with hereditary hemorrhagic telangiectasia and pulmonary hypertension in the United States from 2000 to 2014. HHT
94  2019 Hypoxia-induced pulmonary hypertension and chronic lung disease: caveolin-1 dysfunction an important underlying feature. Cav-1
95  2019 Identifying chronic thromboembolic pulmonary hypertension through the French national hospital discharge database. CTEPH, PE
96  2019 Idiopathic hypereosinophilic syndrome with pulmonary hypertension. RHC
97  2019 Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management. CVD, HF, ILD, IPF
98  2019 Imaging of pulmonary hypertension: Pictorial essay. DECT
99  2019 Imatinib for right heart failure in COPD. COPD
100  2019 Impact of Dialysis on the Prognosis of Patients Undergoing Transcatheter Aortic Valve Implantation. adjOR, CI, ESRD, TAVI, VARC